Vivos Inc (RDGL) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Vivos Inc  (RDGL)
 

Vivos Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Vivos Inc's inventory turnover ratio, the ratio that measures Vivos Inc's ability to manage its supply chain, sequentially decreased to 2.27 in the first quarter 2026, which does not come as a surprise, as the Vivos Inc continue to experience headwinds, which also impact its supply chain. Vivos Inc's average inventory processing period in the Mar 31 2026 quarter, has increased to 161 days, from 145 days, in the Dec 31 2025 quarter.

Within Healthcare sector 170 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 1181, from total ranking in the fourth quarter 2025 at 1230.

RDGL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Vivos Inc Market Share?

What is Inventory Turnover Ratio?




RDGL Inventory Turnover Ratio (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 168.25 % - - - -
Y / Y Cost of Sales Growth 23.04 % 71.11 % 274.94 % 361.53 % 298.12 %
Inventory Turnover Ratio (TTM) 2.27 2.51 3.17 5.03 12.61
RDGL's Total Ranking # 1181 # 1230 # 0 # 0 # 0
Average inventory processing period 160 145 115 73 29
Seq. Inventory Growth -0.69 % -8.73 % -0.36 % 197.01 % -
Seq. Cost of Sales Growth 58.26 % 89.57 % -70.47 % 38.85 % 120.09 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 69
Healthcare Sector # 171
Overall Market # 1181

Inventory Turnover Ratio Statistics
High Average Low
2.51 2.39 2.27
(Dec 31 2025)   (Mar 31 2026)




Financial Statements
Vivos Inc's Inventories $ 0 Millions Visit RDGL's Balance sheet
Vivos Inc's Cost of Revenues TTM $ 0 Millions Visit RDGL's Income Statement
What are RDGL's Sales? Visit RDGL's Sales by Segment

Other Inventory Turnover Ratios
Vivos Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
RDGL's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for RDGL's Competitors
Inventory Turnover Ratio for RDGL's Suppliers
Inventory Turnover Ratio for RDGL's Customers

You may also want to know
RDGL's Sales Growth Rates RDGL's Pe Price to earnings ratio RDGL's Receivables Turnover Ratio RDGL's Stock Quote
RDGL's Net Income Growth Rates RDGL's Ps Price to Sales ratio RDGL's Sales per Employee RDGL's Asset Turnover Ratio
RDGL's Net Margin RDGL's Pb Price to Book ratio RDGL's Financial Strength Ratios RDGL's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Hims and Hers Health Inc   6.58 $ 670.000  Millions$ 102  Millions
Vanda Pharmaceuticals Inc   6.54 $ 12.682  Millions$ 2  Millions
Twist Bioscience Corporation  6.50 $ 196.251  Millions$ 30  Millions
Phathom Pharmaceuticals Inc   6.48 $ 30.871  Millions$ 5  Millions
Precision Optics Corporation Inc   6.47 $ 24.932  Millions$ 4  Millions
Nuo Therapeutics Inc   6.42 $ 1.331  Millions$ 0  Millions
Collegium Pharmaceutical Inc   6.41 $ 256.071  Millions$ 40  Millions
Veracyte Inc   6.05 $ 132.000  Millions$ 22  Millions
Kewaunee Scientific Corporation  5.98 $ 200.155  Millions$ 33  Millions
Adm Tronics Unlimited Inc   5.93 $ 1.992  Millions$ 0  Millions
Align Technology inc   5.81 $ 1,327.000  Millions$ 228  Millions
Transmedics Group Inc   5.71 $ 260.151  Millions$ 46  Millions
Opko Health Inc   5.69 $ 372.048  Millions$ 65  Millions
Avantor Inc   5.55 $ 4,447.000  Millions$ 801  Millions
Steris Plc  5.27 $ 3,309.400  Millions$ 628  Millions
Bristol myers Squibb Company  5.24 $ 14,324.000  Millions$ 2,735  Millions
Harrow Inc   5.11 $ 69.568  Millions$ 14  Millions
Integer Holdings Corporation  5.11 $ 1,365.000  Millions$ 267  Millions
Tactile Systems Technology Inc   5.08 $ 81.000  Millions$ 16  Millions
Integrated Biopharma Inc  4.96 $ 45.000  Millions$ 9  Millions
Ufp Technologies Inc   4.95 $ 436.000  Millions$ 88  Millions
Polomar Health Services, Inc.  4.79 $ 0.642  Millions$ 0  Millions
Henry Schein Inc   4.70 $ 9,209.000  Millions$ 1,959  Millions
Bionexus Gene Lab Corp   4.70 $ 4.191  Millions$ 1  Millions
Medinotec Inc   4.69 $ 4.864  Millions$ 1  Millions
West Pharmaceutical Services Inc   4.68 $ 2,052.000  Millions$ 439  Millions
Scilex Holding Company  4.48 $ 14.462  Millions$ 3  Millions
Guardant Health Inc   4.41 $ 379.203  Millions$ 86  Millions
Idexx Laboratories Inc  4.38 $ 1,690.942  Millions$ 386  Millions
Envista Holdings Corporation  4.36 $ 1,267.000  Millions$ 290  Millions

Date modified: 2026-09-08T15:11:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.